Loading the company…
Loading the company…
In the last ten years FDA made 6 decisions for Poseidon Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2017 (3). The latest was on 2020-10-04.
| Family | Decisions on record |
|---|---|
| Coronary intervention (PCI) | 6 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2020-10-04 | PMA | P150039-S005 | Tryton Side Branch Stent · Postapproval Study Protocol |
| 2019-07-02 | PMA | P150039-S004 | Tryton Side Branch Stent · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2018-03-28 | PMA | P150039-S003 | TRYTON Side Branch Stent · Labeling Change - PAS |
| 2017-08-10 | PMA | P150039-S002 | Tryton Side Branch Stent · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2017-07-13 | PMA | P150039-S001 | TRYTON Side Branch Stent · Postapproval Study Protocol - OSB |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Poseidon Medical.